US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Alturas Minerals Corporation (PK) (ALTCF) 銘柄情報

Alturas Minerals Corporation (PK) (ALTCF)

0.0009

0.00

(0.00%)

終了 6月16日 5:00AM

Alturas Minerals Corporation (PK) (ALTCF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.0009

( - )

買値

0.0005

売値

0.0009

出来高

-

0.00 日の範囲 0.00

0.00045 52 週間の範囲 0.012

時価総額

前日終値

0.0009

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 184,928

発行済株式数

145,632,143

配当利回り

PER

-8.37

1 株当たり利益 (EPS)

-0

歳入

-

純利益

-124.74k

Alturas Minerals Corp., together with its subsidiaries, focuses on the exploration and development of mineral properties in Peru and Chile. The company explores for copper-gold porphyry/skarn deposits and epithermal gold mineralized deposits. The company’s projects include Resguardo Copper-Gold Proj... Alturas Minerals Corp., together with its subsidiaries, focuses on the exploration and development of mineral properties in Peru and Chile. The company explores for copper-gold porphyry/skarn deposits and epithermal gold mineralized deposits. The company’s projects include Resguardo Copper-Gold Project located in northeast of Copiapó, northern Chile; and Copperlode Property. Alturas Minerals Corp. is based in Toronto, Canada. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

www.alturasminerals.com

本社

Toronto, Canada

設立

-

Alturas Minerals Corporation (PK) is listed in the Materials sector of the その他OTC with ticker ALTCF. The last closing price for Alturas Minerals (PK) was US$0. Over the last year, Alturas Minerals (PK) shares have traded in a share price range of US$ 0.00045 to US$ 0.012.

Alturas Minerals (PK) currently has 145,632,143 shares in issue. The market capitalisation of Alturas Minerals (PK) is US$131,068.93 . Alturas Minerals (PK) has a price to earnings ratio (PE ratio) of -8.37.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.0009	0.0009	0.0009	3672	0.0009	CS
26	-0.0028	-75.6756756757	0.0037	0.012	0.00045	8100	0.00430454	CS
52	-0.0111	-92.5	0.012	0.012	0.00045	6320	0.00424968	CS
156	-0.0111	-92.5	0.012	0.012	0.00045	7313	0.00337436	CS
260	-0.0111	-92.5	0.012	0.012	0.00045	7313	0.00337436	CS

ALTCF - Frequently Asked Questions (FAQ)

What is the current Alturas Minerals Corporation (PK) share price?

The current share price of Alturas Minerals Corporation (PK) is US$ 0.0009

How many Alturas Minerals Corporation (PK) shares are in issue?

Alturas Minerals Corporation (PK) has 145,632,143 shares in issue

What is the market cap of Alturas Minerals Corporation (PK)?

The market capitalisation of Alturas Minerals Corporation (PK) is USD 131.07k

What is the 1 year trading range for Alturas Minerals Corporation (PK) share price?

Alturas Minerals Corporation (PK) has traded in the range of US$ 0.00045 to US$ 0.012 during the past year

What is the PE ratio of Alturas Minerals Corporation (PK)?

The price to earnings ratio of Alturas Minerals Corporation (PK) is -8.37

What is the registered address of Alturas Minerals Corporation (PK)?

The registered address for Alturas Minerals Corporation (PK) is 372 Bay Street, Toronto, Ontario, M5H 2W9

What is the Alturas Minerals Corporation (PK) website address?

The website address for Alturas Minerals Corporation (PK) is www.alturasminerals.com

Which industry sector does Alturas Minerals Corporation (PK) operate in?

Alturas Minerals Corporation (PK) operates in the Mining sector

biotechinvestor1

biotechinvestor1 8分前

Total nonsense! I have no interest in educating you.

Nemesis18

Nemesis18 9分前

She'll probably move to somewhere without any extradition treaty once the plug is finally pulled on this 'cancer vaccine' scam.?

price_and_volume

price_and_volume 11分前

Gonna have to bump the A/S then...
He said recently that they are looking at another acquisition...and he will dilute with shares to get it. Agreed - I posted the same, "where's the finance coming from for acquisitions?"...

Supposed 400MM shares going to $GTVH (believe it when

StockItOut

StockItOut 12分前

WKSP Weekly chart: https://schrts.co/IIIuZpgy

CelestialSage6

CelestialSage6 13分前

I understand that Halozyme has not signed any exclusive agreements regarding treatments or indications related to Dupixent, so why is Sanofi collaborating with Alteogen?

Also, Halozyme's mdase patent is being invalidated due to Merck. Alteogen's technology is more advanced than Halozy

Wolf-man jack

Wolf-man jack 14分前

WQLF SAYS: Have Mercy WQLF ahoooooo

Q: Why hasn't CV SCIENCES been accepted in the CMS Medicare Pilot Program?

Ai Generated:

CV Sciences has not been "accepted" into the CMS Medicare Pilot Program because the pilot is a provider-led incentive, not a pro

price_and_volume

price_and_volume 16分前

What reasonable expectation is there of PPS responding?
whether management can successfully execute on the vision they have laid out. Nobody cares about "the company" or "the management" or "their vision" or your two-bit-MBA-tutorials-in-a-post.

Enough of all that garbage.

mrwrn2010

mrwrn2010 19分前

Disagree. The outcome of OxyContin litigation was unknown 9 months to a year ago. You can guess at a variety of outcomes, sure, but it’s not certain. Same thing with human trials - we don’t have positive trial results for anything in the pipeline until we have them. What passes in vitro may not pass

PEACHMAN

PEACHMAN 21分前

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177680761

IFUS STRONG

price_and_volume

price_and_volume 22分前

I get that, but that's not what I asked.

I'm not bullying you or accusing you of pumping.

You repeatedly point out what you consider to be nefarious shenanigans, so I asked: PPS hasn't effectively changed in THREE YEARS , other than a few short days 1 year ago this wee

Homework.Investwell

Homework.Investwell 28分前

2017 Northwest Biotherapeutics, Inc.
4800 Montgomery Lane, Suite 800

Suite 800 is empty....🤔

Linda lives in Missouri now but headquarters could be moved anywhere...or will they need it?

I think we're going to find out by the end of the sum

Mdk1

Why this paper is highly interesting for Lightwave Logic (GROK)
This is a top-scored paper that strongly validates Lightwave Logic’s Perkinamine™ chromophore series 3 as a leading electro-optic material for next-generation datacenter optics.

Key Reasons Why It Matters:

janice shell

janice shell 37分前

Now that's a real head-scratcher! But shorts have to be smart, so I'd say torso and head.

gitreal

gitreal 39分前

Anyone with half a Brian can see this company is being crazy shorted!

Which half? Torso and head?

HyGro

NWBO could file an FDA application anytime but they haven't and have shown no intent to do so. Instead they are just burning more shareholder cash and if approved, will lose money on every dose because NICE will hammer the reimbursement down below Advent's costs. NWBO will lose money and collaps

US Market News

US Market News 45分前

TotalEnergies SE: Disclosure of Transactions in Own SharesJune 16, 2026 2:00 AM
Business Wire Regulatory News In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on share

HyGro

Sorry, not enough. NWBO won't make any profit selling in the UK. NICE hates personalized oncology treatments and won't pay enough for NWBO to make a profit.
That's what counts. And NWBO will go under or just become Advent Contract Manufacturer. They have no cash or credit to fund any sub

biotechinvestor1

biotechinvestor1 49分前

Don’t start spazzing again, Alteogen circus clown. The Sanofi news is old.
Once Merck settles/licenses from Halozyme, Sanofi and all others will follow.
Your Alteogen stole IP from Halozyme and will pay a price for it. You can count on it.
The companies who have signed with Alte

Steady_T

Steady_T 49分前

Your theory will be put to the test after UK approval. I give it 6 months as a guess.

HyGro

What's true is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How many years are you going to wait to find out???

HyGro

What's True is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How long are you going to wait to find out???

Mdk1

Google Scholar alert - new article: "A Comparison of Plasmonic Modulator Structures in the O- and C-Band for the 400G/Lane IM/DD Era"
>>> " In ALL cases, the same electro-optic organic material, Lightwave Logic’s PerkinamineTM
chromophore series 3, was used " !
https://ieeexplor

CelestialSage6

CelestialSage6 57分前

Stop talking nonsense. Sanofi is conducting clinical trials using Alteogen's technology; what are your thoughts on this? Did you sense a crisis for Halozyme?

biotechinvestor1

biotechinvestor1 60分前

I love it when Alteogen fanboys post on this board. Nearly every time they show up, Halozyme has a run up.

DR_rugby

DR_rugby 1時間前

Prophecy is coming

https://www.cnbc.com/2026/06/16/boj-rate-hike-historic-inflation.html

Japanese rates are going higher

Yen is yet to be stabilize

The great unwinding is coming soon

GLTA

Alturas Minerals (PK)

1.926% Sec Sus Nts 15/09...

BNP Paribas Issuance

Sterling vs HTG

Quad County Corn Process... (EM)

Ubs Ag London Branch Aut...

Royal Bank of Canada

1.75% until 9dec2049

SAP SE ADRhedged

Orange SA Orange Sa Eo F...

Mackenzie Developed Mrkt...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。